Coronavirus Update With CDC Director Rochelle Walensky
Coronavirus Update With CDC Director Rochelle Walensky
@CDC Director Rochelle P. Walensky, MD, MPH returns to JAMA's Q&A series to discuss the agency's response to emerging variants, implications for the planned vaccine mobilization strategy, the upcoming J&J vaccine FDA advisory hearings, strategies for reopening K-12 schools, and other agency activities and priorities related to COVID-19 control. Originally broadcast February 17, 2021.Topics discussed in this interview:
0:00 Introduction
2:10 How NIAID and CDC are thinking about variants
3:51 CDC strategies
8:06 Global effort to vaccinate
8:40 Surveillance and sequencing scale-up
11:06 Outlook for next few months
14:34 Spread of variants of concern in US
17:37 Opening schools
19:36 Reaction to CDC guidance
24:51 Immunity from natural infection vs vaccines
25:55 J&J vaccine
29:01 Vaccination with prior infection
30:24 Testing and domestic travel
32:08 Physical distancing in schools
33:38 Planning ahead for vaccines
36:03 Family transition
• Earn Free CME credits by watching JAMA Livestreams and completing a brief questionnaire. Claim 0.5 credits for each video at https://ja.ma/covidqa
• Coronavirus Resource page from the JAMA Network: https://ja.ma/covidyt
• To watch all the #JAMALive Q&A's Visit: https://ja.ma/covidqaytpl
• Don't forget to hit subscribe or click https://ja.ma/subscribe
---------------------------------------------------------------------------------
For more from JAMA
• https://www.jama.com
• https://www.facebook.com/JAMAJournal
• https://www.twitter.com/JAMA_Current
• https://www.linkedin.com/company/jamanetwork
Follow the JAMANetwork
• https://www.jamanetwork.com
• http://www.jamanetworkaudio.com
• https://www.facebook.com/JAMANetwork
• https://www.twitter.com/JAMANetwork
• https://www.instagram.com/JAMANetwork
• https://www.pinterest.com/JAMANetwork
=====================================================================
#JAMALive #Coronavirus #Pandemic #COVID19 #SARSCoV2
Access Non-GMO, antigen-free, FDA-approved antiviral medication formulas used in Moderna's Spikevax.
VirusTC is a retail provider of concentrated FDA-approved antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA-approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.